Infection strategies of enteric pathogenic Escherichia coli
A Clements, JC Young, N Constantinou, G Frankel - Gut microbes, 2012 - Taylor & Francis
Enteric Escherichia coli (E. coli) are both natural flora of humans and important pathogens
causing significant morbidity and mortality worldwide. Traditionally enteric E. coli have been …
causing significant morbidity and mortality worldwide. Traditionally enteric E. coli have been …
Cell death and infection: a double-edged sword for host and pathogen survival
H Ashida, H Mimuro, M Ogawa, T Kobayashi… - Journal of Cell …, 2011 - rupress.org
Host cell death is an intrinsic immune defense mechanism in response to microbial infection.
However, bacterial pathogens use many strategies to manipulate the host cell death and …
However, bacterial pathogens use many strategies to manipulate the host cell death and …
Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements
ARC Wong, JS Pearson, MD Bright… - Molecular …, 2011 - Wiley Online Library
The human pathogens enteropathogenic and enterohemorrhagic Escherichia coli (EPEC
and EHEC) share a unique mechanism of colonization that results from the concerted action …
and EHEC) share a unique mechanism of colonization that results from the concerted action …
Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation
J Garmendia, G Frankel, VF Crepin - Infection and immunity, 2005 - Am Soc Microbiol
Escherichia coli is the most abundant facultative anaerobic gram-negative bacterium of the
intestinal microffora, naturally colonizing the mucous layer of the colon. A conserved core …
intestinal microffora, naturally colonizing the mucous layer of the colon. A conserved core …
The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection
T Kobayashi, M Ogawa, T Sanada, H Mimuro, M Kim… - Cell host & …, 2013 - cell.com
Caspase-mediated inflammatory cell death acts as an intrinsic defense mechanism against
infection. Bacterial pathogens deploy countermeasures against inflammatory cell death, but …
infection. Bacterial pathogens deploy countermeasures against inflammatory cell death, but …
Virulence of Enteropathogenic Escherichia coli, a Global Pathogen
SC Clarke, RD Haigh, PPE Freestone… - Clinical microbiology …, 2003 - Am Soc Microbiol
Enteropathogenic Escherichia coli (EPEC) remains an important cause of diarrheal disease
worldwide. Research into EPEC is intense and provides a good virulence model of other E …
worldwide. Research into EPEC is intense and provides a good virulence model of other E …
Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas …
Porphyromonas gingivalis, an important periodontal pathogen, infects primary gingival
epithelial cells (GECs). Despite the large number of bacteria that replicate inside the GECs …
epithelial cells (GECs). Despite the large number of bacteria that replicate inside the GECs …
Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria
B Kenny, M Jepson - Cellular microbiology, 2000 - Wiley Online Library
Many Gram‐negative pathogens use a type III secretion apparatus to deliver effector
molecules into host cells to subvert cellular processes in favour of the pathogen …
molecules into host cells to subvert cellular processes in favour of the pathogen …
Saccharomyces boulardii Preserves the Barrier Function and Modulates the Signal Transduction Pathway Induced in Enteropathogenic Escherichia coli-Infected T84 …
D Czerucka, S Dahan, B Mograbi, B Rossi… - Infection and …, 2000 - Am Soc Microbiol
Use of the nonpathogenic yeast Saccharomyces boulardii in the treatment of infectious
diarrhea has attracted growing interest. The present study designed to investigate the effect …
diarrhea has attracted growing interest. The present study designed to investigate the effect …
Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system
H Stier, SC Bischoff - Clinical and experimental gastroenterology, 2016 - Taylor & Francis
Background The probiotic Saccharomyces boulardii CNCM I-745 (also known as
Saccharomyces cerevisiae HANSEN CBS 5926; in the following S. boulardii) has proven its …
Saccharomyces cerevisiae HANSEN CBS 5926; in the following S. boulardii) has proven its …